Jeremy Curnock Cook - Dec 21, 2023 Form 4/A Insider Report for AVITA Medical, Inc. (RCEL)

Role
Director
Signature
/s/ Donna Shiroma
Stock symbol
RCEL
Transactions as of
Dec 21, 2023
Transactions value $
-$31,225
Form type
4/A
Date filed
12/22/2023, 05:01 PM
Date Of Original Report
Dec 14, 2023
Previous filing
Dec 14, 2023
Next filing
Jun 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Sale -$31.2K -2.5K -10.82% $12.49 20.6K Dec 21, 2023 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover UK tax obligation incurred by the Reporting Person upon the vesting of RSUs
F2 The original Form 4, filed on December 14, 2023, is being amended by this Form 4 to correct an administrative error, which misreported a sale of common stock to cover taxes for vesting of RSUs on the wrong date. The sale of the stock was reported on December 13, 2023, however, the actual sale occured on December 21, 2023. This Form 4 reflects the correction to the date, price and number of shares sold in the transaction.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.39 to $12.64. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4.
F4 Includes unvested RSUs